312 related articles for article (PubMed ID: 31236672)
21. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients.
Rim JH; Choe YB; Youn JI
Photodermatol Photoimmunol Photomed; 2002 Jun; 18(3):131-4. PubMed ID: 12207676
[TBL] [Abstract][Full Text] [Related]
22. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo.
Arca E; Taştan HB; Erbil AH; Sezer E; Koç E; Kurumlu Z
J Dermatol; 2006 May; 33(5):338-43. PubMed ID: 16700666
[TBL] [Abstract][Full Text] [Related]
23. Comparative Study of Efficacy of Topical Mometasone with Calcipotriol versus Mometasone Alone in the Treatment of Alopecia Areata.
Alam M; Amin SS; Adil M; Arif T; Zahra FT; Varshney I
Int J Trichology; 2019; 11(3):123-127. PubMed ID: 31360041
[TBL] [Abstract][Full Text] [Related]
24. Narrowband ultraviolet B phototherapy for alopecia areata.
Bayramgürler D; Demirsoy EO; Aktürk AŞ; Kıran R
Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):325-7. PubMed ID: 22092737
[TBL] [Abstract][Full Text] [Related]
25. A randomized, double-blinded, placebo-controlled trial of pseudocatalase cream and narrowband ultraviolet B in the treatment of vitiligo.
Bakis-Petsoglou S; Le Guay JL; Wittal R
Br J Dermatol; 2009 Oct; 161(4):910-7. PubMed ID: 19523170
[TBL] [Abstract][Full Text] [Related]
26. A comparative study of calcipotriol and anthralin for chronic plaque psoriasis in a day care treatment center.
Dutz JP; Lui H
Int J Dermatol; 1998 Jan; 37(1):51-3. PubMed ID: 9522242
[TBL] [Abstract][Full Text] [Related]
27. Intralesional vitamin D3 in treatment of alopecia areata: A randomized controlled clinical trial.
Rashad AF; Elgamal E; Fouda I
J Cosmet Dermatol; 2022 Oct; 21(10):4617-4622. PubMed ID: 35152536
[TBL] [Abstract][Full Text] [Related]
28. Calcipotriol monotherapy versus calcipotriol plus UVA1 versus calcipotriol plus narrow-band UVB in the treatment of psoriasis.
Roussaki-Schulze AV; Kouskoukis C; Klimi E; Zafiriou E; Galanos A; Rallis E
Drugs Exp Clin Res; 2005; 31(5-6):169-74. PubMed ID: 16425972
[TBL] [Abstract][Full Text] [Related]
29. A clinical and immunological study of phototoxic regimen of ultraviolet A for treatment of alopecia areata: a randomized controlled clinical trial.
El-Mofty M; Rasheed H; El-Eishy N; Hegazy RA; Hafez V; Shaker O; El-Samanoudy SI
J Dermatolog Treat; 2019 Sep; 30(6):582-587. PubMed ID: 30411986
[No Abstract] [Full Text] [Related]
30. Comparative evaluation of the efficacy of topical tacrolimus 0.03% and topical calcipotriol 0.005% mixed with betamethasone dipropionate versus topical clobetasol 0.05% in treatment of alopecia areata: A clinical and trichoscopic study.
Nassar A; Elradi M; Radwan M; Albalat W
J Cosmet Dermatol; 2023 Apr; 22(4):1297-1303. PubMed ID: 36575890
[TBL] [Abstract][Full Text] [Related]
31. Does addition of topical calcipotriol to UVB increase the risk of irritant reactions in psoriasis? The Calcipotriol-UVB Study Group.
Molin L
Acta Derm Venereol; 1997 Sep; 77(5):401-2. PubMed ID: 9298141
[No Abstract] [Full Text] [Related]
32. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group.
Ramsay CA; Schwartz BE; Lowson D; Papp K; Bolduc A; Gilbert M
Dermatology; 2000; 200(1):17-24. PubMed ID: 10681608
[TBL] [Abstract][Full Text] [Related]
33. Synergism between narrowband ultraviolet B phototherapy and etanercept for the treatment of plaque-type psoriasis.
Calzavara-Pinton PG; Sala R; Arisi M; Rossi MT; Venturini M; Ortel B
Br J Dermatol; 2013 Jul; 169(1):130-6. PubMed ID: 23834117
[TBL] [Abstract][Full Text] [Related]
34. Alefacept for severe alopecia areata: a randomized, double-blind, placebo-controlled study.
Strober BE; Menon K; McMichael A; Hordinsky M; Krueger G; Panko J; Siu K; Lustgarten JL; Ross EK; Shapiro J
Arch Dermatol; 2009 Nov; 145(11):1262-6. PubMed ID: 19917955
[TBL] [Abstract][Full Text] [Related]
35. [Topical treatment of psoriasis with calcipotriol. Report of clinical experience].
Hofmann C; Schirle S
Fortschr Med; 1993 Dec; 111(35-36):562-4. PubMed ID: 8307546
[TBL] [Abstract][Full Text] [Related]
36. A comparative study on the use of fractional CO
Bakr RM; Abdel-Gaber RM; Tawfik YM
Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
[TBL] [Abstract][Full Text] [Related]
37. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo.
Ada S; Sahin S; Boztepe G; Karaduman A; Kölemen F
Photodermatol Photoimmunol Photomed; 2005 Apr; 21(2):79-83. PubMed ID: 15752125
[TBL] [Abstract][Full Text] [Related]
38. A randomized, double-blind, negatively controlled pilot study to determine whether the use of emollients or calcipotriol alters the sensitivity of the skin to ultraviolet radiation during phototherapy with narrowband ultraviolet B.
Skellett A; Swift L; Tan E; Garioch J
Br J Dermatol; 2011 Feb; 164(2):402-6. PubMed ID: 20969563
[TBL] [Abstract][Full Text] [Related]
39. [Market hyperpigmentation in psoriatic plaque as a sequelae of combination therapy with UVB-311 and calcipotriol].
Rütter A; Schwarz T
Hautarzt; 2000 Jun; 51(6):431-3. PubMed ID: 10907160
[TBL] [Abstract][Full Text] [Related]
40. Duration of remission period of narrowband ultraviolet B therapy on psoriasis vulgaris.
Karakawa M; Komine M; Takekoshi T; Sakurai N; Minatani Y; Tada Y; Saeki H; Tamaki K
J Dermatol; 2011 Jul; 38(7):655-60. PubMed ID: 21352300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
